Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Change In Inventory : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Change In Inventory?

Shenzhen Hepalink Pharmaceutical Group Co's change in inventory for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Shenzhen Hepalink Pharmaceutical Group Co's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Shenzhen Hepalink Pharmaceutical Group Co's change in inventory for the fiscal year that ended in Dec. 2024 was ¥1,245 Mil. It means Shenzhen Hepalink Pharmaceutical Group Co's inventory declined by ¥1,245 Mil from Dec. 2023 to Dec. 2024 .

Shenzhen Hepalink Pharmaceutical Group Co's Total Inventories for the quarter that ended in Mar. 2025 was ¥4,953 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory for the quarter that ended in Mar. 2025 was 465.98.

Inventory Turnover measures how fast the company turns over its inventory within a year. Shenzhen Hepalink Pharmaceutical Group Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.20.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Shenzhen Hepalink Pharmaceutical Group Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 3.71.

Shenzhen Hepalink Pharmaceutical Group Co Change In Inventory Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Change In Inventory Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-763.88

-1,520.24

-2,151.56

-619.67

1,244.71

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhen Hepalink Pharmaceutical Group Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shenzhen Hepalink Pharmaceutical Group Co (SZSE:002399) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Shenzhen Hepalink Pharmaceutical Group Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5173.3405	/	1013.068	*	365 / 4
	=	465.98

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Shenzhen Hepalink Pharmaceutical Group Co's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1013.068	/	5173.3405
	=	0.20

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Shenzhen Hepalink Pharmaceutical Group Co's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5173.3405	/	1394.25
	=	3.71

Shenzhen Hepalink Pharmaceutical Group Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Hepalink Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (SZSE:002399) » Definitions » Change In Inventory

Traded in Other Exchanges

09989:Hong Kong

Address

No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057

Website

https://www.hepalink.com

Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business, and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from USA and Europe.

Executives

Zhang Ping	Director
Li Li	Director
Kong Yun	Executives
Li Tan	Directors, executives

Shenzhen Hepalink Pharmaceutical Group Co Headlines

No Headlines